These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 34558278)

  • 1. Evaluation of circulating CD34+ stem cells in peripheral venous blood in patients with varying degrees of periodontal disease.
    Aleksandrowicz P; Kotuła LZ; Grabowska K; Krakowiak RL; Kusa-Podkańska M; Agier J; Gorący A; Kądziołka KE; Kocki J; Wysokińska-Miszczuk J
    Ann Agric Environ Med; 2021 Sep; 28(3):516-520. PubMed ID: 34558278
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of periodontal treatment on circulating CD34(+) cells and peripheral vascular endothelial function: a randomized controlled trial.
    Li X; Tse HF; Yiu KH; Li LS; Jin L
    J Clin Periodontol; 2011 Feb; 38(2):148-56. PubMed ID: 21133981
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Effect of growth factor on the phenotype of subpopulations and on the kinetics of CD34+ cells in the peripheral blood and in grafts of peripheral stem cells in patients with non-Hodgkin's lymphoma indicated for autologous peripheral blood stem cell transplantation].
    Klabusay M; Lysák D; Hrabcáková V; Navrátil M; Coupek P; Mayer J
    Cas Lek Cesk; 2008; 147(6):319-24. PubMed ID: 18724529
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term Prediction of Cardiovascular Outcomes by Circulating CD34+ and CD34+CD133+ Stem Cells in Patients With Type 2 Diabetes.
    Fadini GP; Rigato M; Cappellari R; Bonora BM; Avogaro A
    Diabetes Care; 2017 Jan; 40(1):125-131. PubMed ID: 27815289
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Circulating apoptotic progenitor cells: a novel biomarker in patients with acute coronary syndromes.
    Schwartzenberg S; Deutsch V; Maysel-Auslender S; Kissil S; Keren G; George J
    Arterioscler Thromb Vasc Biol; 2007 May; 27(5):e27-31. PubMed ID: 17332488
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased levels of circulating endothelial progenitor cells in subjects with moderate to severe chronic periodontitis.
    Li X; Tse HF; Yiu KH; Jia N; Chen H; Li LS; Jin L
    J Clin Periodontol; 2009 Nov; 36(11):933-9. PubMed ID: 19799717
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Changes in CD34+ cell count in peripheral blood after whole blood donation.
    Pala C; Mumcuoglu H; Kurnaz F; Sivgin S; Kaynar L; Keklik M; Akyol G; Koker Y; Eser B
    Transfus Apher Sci; 2013 Oct; 49(2):259-62. PubMed ID: 23683897
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased levels of circulating CD34+ cells in neovascular age-related macular degeneration: relation with clinical and OCT features.
    Kara C; Özdal PÇ; Beyazyıldız E; Özcan NE; Teke MY; Vural G; Öztürk F
    Eur J Ophthalmol; 2018 Jan; 28(1):80-86. PubMed ID: 28777387
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Entecavir promotes CD34⁺ stem cell proliferation in the peripheral blood and liver of chronic hepatitis B and liver cirrhosis patients.
    Lv B; Zhao H; Bai X; Huang S; Fan Z; Lu J; Tang R; Yin K; Gao P; Liu B; Cheng J
    Discov Med; 2014 Nov; 18(100):227-36. PubMed ID: 25425463
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Circulating angiogenic cytokines and stem cells in patients with severe chronic ischemic heart disease--indicators of myocardial ischemic burden?
    Ripa RS; Wang Y; Goetze JP; Jørgensen E; Johnsen HE; Tägil K; Hesse B; Kastrup J
    Int J Cardiol; 2007 Aug; 120(2):181-7. PubMed ID: 17157396
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CD34+ progenitor cells in pulmonary sarcoidosis.
    Płusa T; Chełstowska S
    Pol Merkur Lekarski; 2015 May; 38(227):250-3. PubMed ID: 26039017
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Circulating CD34+ KDR+ endothelial progenitor cells correlate with erectile function and endothelial function in overweight men.
    Esposito K; Ciotola M; Maiorino MI; Giugliano F; Autorino R; De Sio M; Jannini E; Lenzi A; Giugliano D
    J Sex Med; 2009 Jan; 6(1):107-14. PubMed ID: 19170841
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Collection of peripheral blood progenitor cells (PBPC) based on a rising WBC and platelet count significantly increases the number of CD34+ cells.
    Krieger MS; Schiller G; Berenson JR; Stewart K; Noga SJ; Ballester O; Tarantolo S; Stiff P; Kuhn D; Scherzo E; Sing A; Jacobs C; White JM; DiPersio J
    Bone Marrow Transplant; 1999 Jul; 24(1):25-8. PubMed ID: 10435730
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Involvement of circulating endothelial progenitor cells and vasculogenic factors in the pathogenesis of diabetic retinopathy.
    Lee IG; Chae SL; Kim JC
    Eye (Lond); 2006 May; 20(5):546-52. PubMed ID: 15905870
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Poor graft function can be durably and safely improved by CD34+-selected stem cell boosts after allogeneic unrelated matched or mismatched hematopoietic cell transplantation.
    Haen SP; Schumm M; Faul C; Kanz L; Bethge WA; Vogel W
    J Cancer Res Clin Oncol; 2015 Dec; 141(12):2241-51. PubMed ID: 26272482
    [TBL] [Abstract][Full Text] [Related]  

  • 16. BIRMA-K3, a new monoclonal antibody for CD34 immunophenotyping and stem and progenitor cell assay.
    Höffkes HG; Lowe JA; Pedersen RO; Schmidkte G; McDonald DF
    J Hematother; 1996 Jun; 5(3):261-70. PubMed ID: 8817393
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The number of circulating CD34 positive cells is the best preleukapheresis parameter for predicting the quality of peripheral blood progenitor cell harvest.
    Feugier P; Schooneman F; Humbert JC; Bordigoni P; Witz F; Monnez JM; Janot C
    Nouv Rev Fr Hematol (1978); 1995; 37(6):301-5. PubMed ID: 8907623
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Isolation and transplantation of highly purified autologous peripheral CD34+progenitor cells: purging efficacy, hematopoietic reconstitution following high dose chemotherapy in patients with breast cancer: results of a feasibility study in Japan.
    Chou T; Sano M; Ogura M; Morishima Y; Itagaki H; Tokuda Y
    Breast Cancer; 2005; 12(3):178-88. PubMed ID: 16110287
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The implication of circulating CD34+ Thy-1(+) cells measurement during autologous peripheral blood stem cell mobilization].
    Yang B; Wang L; Chen P
    Zhonghua Xue Ye Xue Za Zhi; 1997 Aug; 18(8):406-9. PubMed ID: 15625845
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mobilisation of peripheral blood stem cells with IVE and G-CSF improves CD34+ cell yields and engraftment in patients with non-Hodgkin's lymphomas and Hodgkin's disease.
    McQuaker I; Haynes A; Stainer C; Byrne J; Russell N
    Bone Marrow Transplant; 1999 Oct; 24(7):715-22. PubMed ID: 10516673
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.